B · Normal
[CRO concept repeatedly active, Yiqiao Shenzhou rose more than 10%] On September 23, the CRO concept repeatedly became active, Yiqiao Shenzhou rose more than 10%, Nanhua Biotech hit the daily limit, Yinuosi, Aoxiang Pharmaceutical, Porton Biotechnology, and Heyuan Biotech followed the rise. In terms of news, the latest research report from Huayuan Securities pointed out that the innovative drug industry is improving in multiple dimensions, and the demand for CRO is gradually recovering. China's dual-sided policy environment for approval and payment of innovative drugs has improved, clinical CRO demand continues to recover, and the market is expected to continue to expand.
Live broadcast 🕐 2026-09-23 09:39
#Live broadcast #CRO
Save as Image Generate a beautiful long image to share on Moments or in group chats Generate now ⬇
← Back to Telegraph

Related telegraphs

[Scientific instrument sector fluctuated higher, Unilide and Oriental Zhongke bo 09-23 11:17 September 23rd, data showed that today the price of MMLC battery grade lithium c 09-23 11:07 [Cultivation diamond concept rebounded with shock and Hongchang Technology rose 09-23 11:03 [Main Fund Monitoring: Woge Optoelectronics has a net purchase of nearly 900 mil 09-23 10:58 [The transaction volume of the Shanghai and Shenzhen stock markets exceeded 1 tr 09-23 10:56 [CPO concept rebounded in shock, Fuxin Technology hit the 20cm daily limit] On S 09-23 10:42

Comments

0/500
Captcha (click to refresh)
No comments yet